Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use.
| Autor: | Chen BA; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh/Magee-Womens Research Institute, Pittsburgh, Pennsylvania; the Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia; the Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan; and the Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, and Medicines360, San Francisco, and the Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, California., Kimble T, Harris LH, Kerns JL, Olariu AI, Creinin MD |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Obstetrics and gynecology [Obstet Gynecol] 2023 May 01; Vol. 141 (5), pp. 1004-1006. Date of Electronic Publication: 2023 Apr 05. |
| DOI: | 10.1097/AOG.0000000000005147 |
| Abstrakt: | Funding Source: Medicines360. The Sponsor, Medicines360, designed the study and oversaw its conduct, including funding the trial and providing all study product free of charge to participants. Clinical Trial Registration: ClinicalTrials.gov, NCT00995150. (Copyright © 2023 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|